迈博药业-B（02181）于2026年5月6日发布截至2026年4月30日止月报表。报告显示，公司注册股本维持在50,000,000,000股，面值每股0.0001美元，总额5,000,000美元，与上月持平。
报告期末，迈博药业-B已发行股份为4,124,080,000股，无库存股份，总股本与上月保持一致，未发生新增发行、购回或注销。公司所实施的股份期权计划维持在72,670,876份期权，报告期内无行权、授出或作废记录。
公告显示，迈博药业-B当前已符合港交所对最低公众持股量的要求，并声明遵守香港联交所《上市规则》及相关法规。本次公告由公司秘书曾浩贤先生签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.